POLA2 has been implicated in a wide variety of tumor types (breast cancer, bladder cancer, glioblastoma multiforme, gastrointestinal stromal tumor, non-small cell lung cancer, ovarian cancer) and serves as a prognostic marker for patients. This evidence concerns the gene POLA2 and urinary bladder carcinoma.